¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Purpura, Sch"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® purpura ÇÑ±Û ÀÚ»ö¹ÝÁõ
¼³¸í   
  ÇǺγ»ÀÇ ÃâÇ÷·Î ÀÎÇÏ¿©, ÇǺΠǥÇǸ¦ ÅëÇÏ¿© ½±°Ô º¸À̴ ÀÚÈ«»ö È¤Àº Àû°¥»ö ¹ÝÁ¡À» Æ¯Â¡À¸·Î Çϴ ÀÏ·ÃÀÇ ÁúȯÀ» ÃÑĪÇϴ ¿ë¾îÀÌ´Ù. ´ë°³ È«¹Ý°ú ±¸º°ÇؾߠÇϴ µ¥ È«¹ÝÀº ÇǺιØÀÇ Ç÷°üÀÌ ÆØÃ¢ÇÏ¿© ºÓ°Ô º¸À̴ Çö»óÀ¸·Î Åõ¸íÇÑ ÀÚ¸¦ ÀÌ¿ëÇÏ¿© ÇǺθ¦ ´­·¯¼­ °üÂûÇØº¸¸é ½±°Ô ±¸º°ÀÌ °¡´ÉÇÏ´Ù. À̶§ È«¹ÝÀº ºÓÀº »öÀÌ ¾ø¾îÁöÁö¸¸, ÀÚ¹ÝÀº ºÓÀº »öÀÌ ¾ø¾îÁöÁö ¾Ê´Â´Ù.
  
  
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • angioneurotic purpura
    Ç÷°ü½Å°æÀÚ»ö¹Ýº´
  • athrombocytopenic purpura
    ºñÀúÇ÷¼ÒÆÇÀÚ»ö¹Ýº´
  • allergic purpura
    ¾Ë·¹¸£±âÀÚ»ö¹Ýº´
  • anaphylactoid purpura
    ¾Æ³ªÇʶô½Ã½ºÀÚ»ö¹Ýº´
  • drug-induced purpura
    ¾à¹°À¯¹ßÀÚ»ö¹Ý
  • dysproteinemic purpura
    ÀÌ»ó´Ü¹éÇ÷ÀÚ»ö¹Ý
  • factitious purpura
    ÀΰøÀÚ»ö¹Ý
  • flat purpura
    ÆíÆòÀÚ»ö¹Ý
  • fulminans purpura
    Àü°ÝÀÚ»ö¹Ýº´, µ¹¹ßÀÚ»ö¹Ýº´
  • gangrenous purpura
    ±«ÀúÀÚ»ö¹Ý
  • hyperglobulinemic purpura
    °í±Û·ÎºÒ¸°Ç÷ÀÚ»ö¹Ý
  • hemorrhagic purpura
    ÃâÇ÷ÀÚ»ö¹Ý
  • Henoch-Schonlein purpura
    Çì³ëÈå-¼é¶óÀÎÀÚ»ö¹Ý
  • Henoch-Schonlein purpura nephritis
    Çì³ëÈå-¼é¶óÀÎÀÚ»ö¹ÝÄáÆÏ¿°, Çì³ëÈå-¼é¶óÀÎÀÚ»ö¹Ý½ÅÀå¿°
  • itching purpura
    °¡·Á¿òÀÚ(»ö)¹Ý
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Henoch-Schoenlein purpura nephritis
    Çì³ëÈ彨¶óÀÎÀÚ»ö¹ÝÄáÆÏ¿°, Çì³ëÈ彨¶óÀÎÀÚ»ö¹Ý½ÅÀå¿°
  • purpura
    ÀÚ»ö¹Ý, ÀÚ»ö¹Ýº´
  • Henoch-Schonlein purpura
    Çì³ëÈ£½¨¶óÀÎÀÚ»ö¹Ý
  • immune thrombocytopenic purpura
    ¸é¿ªÇ÷¼ÒÆÇ°¨¼ÒÀÚ»ö¹Ý
  • palpable purpura
    ÃËÁöÀÚ»ö¹Ý
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • allergic purpura
    ¾Ë·¹¸£±âÀÚ»ö¹ÝÁõ
  • anaphylactoid purpura
    ¾Æ³ªÇʶô½Ã½ºÀÚ»ö¹ÝÁõ
  • angioneurotic purpura
    Ç÷°ü½Å°æÀÚ»ö¹ÝÁõ
  • athrombocytopenic purpura
    Ç÷¼ÒÆÇºñ°¨¼Ò¼ºÀÚ»ö¹ÝÁõ
  • bullous purpura
    ¼öÆ÷ÀÚ»ö¹Ý, ¹°ÁýÀÚ»ö¹Ý
  • drug-induced purpura
    ¾à¹°À¯¹ßÀÚ»ö¹Ý
  • dysproteinemic purpura
    ÀÌ»ó´Ü¹éÇ÷ÀÚ»ö¹Ý
  • factitious purpura
    ÀΰøÀÚ»ö¹Ý
  • flat purpura
    ÆíÆòÀÚ»ö¹Ý
  • fulminant purpura
    Àü°ÝÀÚ»ö¹Ý
  • gangrenous purpura
    ±«ÀúÀÚ»ö¹Ý
  • hemorrhagic purpura
    ÃâÇ÷ÀÚ»ö¹Ý
  • hyperglobulinemic purpura
    °í±Û·ÎºÒ¸°Ç÷ÀÚ»ö¹Ý
  • idiopathic thrombocytopenic purpura
    Ư¹ßÇ÷¼ÒÆÇ°¨¼ÒÀÚ»ö¹Ýº´
  • itching purpura
    °¡·Á¿îÀÚ»ö¹Ý
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Henoch s purpura
    Çì³ëÈ£Àڹݺ´.
  • TTP=£¾thrombotic thrombocytopenic purpura
    Ç÷Àü¼º Ç÷¼ÒÆÇ°¨¼ÒÀÚ¹ÝÁõ.
  • allergic purpura
    ¾Ë·¹¸£±â(¼º) ÀÚ¹ÝÁõ(í¹Úèñø)
  • anaphylactoid purpura
    ¾Æ³ªÇʶô½Ã¾ç Àڹݺ´(¡­í¹ÚèÜ»)
  • anaphylactoid purpura
    ¾Æ³ªÇʶô½Ã¾ç Àڹݺ´(¡­í¹ÚèÜ»).
  • annularis telangiectodes purpura
    ¸ð¼¼Ç÷°ü È®À强 ȯ»óÀÚ¹Ý
  • gangrenous purpura
    ±«Àú¼º ÀÚ¹Ý(¡­í¹Úè)
  • hemorrhagic purpura
    ÃâÇ÷(¼º) ÀÚ¹Ý(º´)
  • henoch-schonlein purpura
    Çì³ëÈ£-½¦¶óÀÎ (Henoch-Schonlein) ÀÚ¹ÝÁõ
  • hypergammaglobulinemic purpura
    °ú°¨¸¶±Û·ÎºÒ¸°Ç÷¼º ÀÚ¹Ý(º´)
  • hyperglobulinemic purpura
    °ú±Û·ÎºÒ¸°Ç÷¼º ÀÚ¹Ý(º´)
  • hypersplenic purpura
    ºñ±â´ÉÇ×Áø¼º ÀÚ¹Ý(Áõ).
  • idiopathic thrombocytopenic purpura
    Ư¹ß¼ºÇ÷¼ÒÆÇ°¨¼Ò¼ºÀڹݺ´(¡­úìá³÷ùÊõá´àõí¹ÚèÜ»)
  • idiopathic thrombocytopenic purpura =ITP
    Ư¹ß¼º Ç÷¼ÒÆÇ °¨¼Ò¼º Àڹݺ´.
  • idopathic thrombocytopenic purpura
    Ư¹ß¼º Ç÷¼ÒÆÇ°¨¼Ò¼º ÀÚ¹ÝÁõ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • albers-sch berg disease
    ¾Ëº£¸£½º-½¨º£¸£Å© º´(¡­Ü»)
  • purulent purpura = suppurative purpura
    È­³ó¼ºÀÚ¹Ý
  • allergic purpura
    ¾Ë·¹¸£±â(¼º) ÀÚ¹ÝÁõ(í¹Úèñø)
  • anaphylactoid purpura
    ¾Æ³ªÇʶô½Ã¾ç Àڹݺ´(¡­í¹ÚèÜ»).
  • anaphylactoid purpura
    ¾Æ³ªÇʶô½Ã¾ç Àڹݺ´(¡­í¹ÚèÜ»)
  • angioneurotic purpura
    Ç÷°ü½Å°æ¼º Àڹݺ´(¡­í¹ÚèÜ»).
  • annularis telangiectodes purpura
    ¸ð¼¼Ç÷°ü È®À强 ȯ»óÀÚ¹Ý
  • athrombocytopenic purpura
    Ç÷¼ÒÆÇºñ°¨¼Ò¼º ÀÚ¹ÝÁõ(úìá³÷ùÞªÊõá´àõí¹Úèñø).
  • athrombocytopenic purpura
    Ç÷¼ÒÆÇºñ°¨¼Ò¼º Àڹݺ´(úìá³÷ùÞªÊõá´àõí¹ÚèÜ»)
  • athrombocytopenic purpura
    Ç÷¼ÒÆÇºñ°¨¼Ò¼º Àڹݺ´(Ì´ËÛ̬?˧ËÛËÛËöËÑËÓ).
  • bullous purpura
    ¼öÆ÷¼º ÀÚ¹Ý
  • corticosteroid purpura
    ÄÚ¸£Æ¼ÄÚ½ºÅ×·ÎÀ̵åÀÚ¹ÝÁõ.
  • drug-induced purpura
    ¾à¹° À¯¹ß ÀÚ¹Ý(º´)(í¹Úè
  • dysproteinemic purpura
    ÀÌ»ó ´Ü¹éÇ÷¼º ÀÚ¹Ý(º´)
  • easy bruising syndrome => purpura simplex
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hemorrhagic purpura
    ÃâÇ÷¼ºÀڹݺ´
  • Henoch's purpura
    Çì³ëÈ£Àڹݺ´
  • idiopathic thrombocytopenic purpura
    Ư¹ß¼ºÇ÷¼ÒÆÇ °¨¼Ò¼º Àڹݺ´
  • purpura
    ÀÚ¹Ý, Àڹݺ´
  • thrombasthenic purpura
    Ç÷¼ÒÆÇÃë¾à¼º Àڹݺ´
  • thrombocytopenic purpura
    Ç÷¼ÒÆÇ°¨¼Ò¼ºÀÚ¹ÝÁõ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ITP idiopathic thrombocytopenic purpura; immune thrombocytopenia; immunogenic thrombocytopenic purpura; ...
SCH student contact hour; succinylcholine
SCh succinylchloride; succinylcholine
ATP   1) Adenosine Tri-Phosphate
  2) Autoimmune Thrombocytopenic Purpura
HSP Henoch Schonlein Purpura
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
Sch B Schisandrin B
SCh Succinylcholine
SCH schizophrenia
SCH suprachiasmatic nucleus
AITP Autoimmune thrombocytopenic purpura
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • acute idiopathic thrombocytopenic purpura
    ±Þ¼º Ư¹ß¼º Ç÷¼ÒÆÇ °¨¼Ò¼º ÀÚ¹Ý º´
  • drug-induced thrombocytopenic purpura
    ¾à¹°¼º Ç÷¼ÒÆÇ °¨¼Ò¼º ÀÚ¹ÝÁõ
  • dysproteinemic purpura
    ÀÌ»ó ´Ü¹éÇ÷¼º Àڹݺ´
  • fibrinolytic purpura
    ¼¶À¯¼Ò ¿ëÇØ¼º ÀÚ¹Ý
    µ¿ÀǾî=
  • hemorrhagic purpura
    ÃâÇ÷¼º Àڹݺ´
  • neonatal purpura fulminans
    Àü°Ý¼º ½Å»ý¾Æ ÀÚ¹Ý
  • nonthrombocytopenic purpura
    ºñÇ÷¼ÒÆÇ °¨¼Ò¼º ÀÚ¹ÝÁõ
  • purpura
    ÀÚ¹Ý, Àڹݺ´, ÀÚ¹ÝÁõ
    Àá»ó ÃâÇ÷°ú Á¡»ó ÃâÇ÷À» ÇÕÇÑ º´º¯. Àü½ÅÀÇ ÇÇÇϳª Á¡¸·¿¡ ÃâÇ÷ÀÌ ÀϾ¼­ ÀÚ»öÀÇ ÀÛÀº ¹ÝÁ¡ÀÌ »ý±â´Â º´. ÀÚ¹ÝÀº Á¡»ó ÃâÇ÷ ¹Ý ¶Ç´Â ÇÇÇÏ ÀÏÇ÷ ¹ÝÀ¸·Î¼­, »õ·Î »ý±ä °ÍÀº ºÓÀº »öÀ» ¶ì°í, ½Ã°£ÀÇ °æ°ú¿Í ÇÔ²² ´Ù°¥»ö¿¡¼­ Ȳ»öÀ¸·Î º¯Çذ¡´Â °Íµµ ÀÖ´Ù. ÃâÇ÷¼º ¼ÒÀÎ Áß ÁÖ·Î Ç÷°ü º®ÀÇ ÀÌ»ó¿¡ ÀÇÇÑ °Í°ú Ç÷¼ÒÆÇÀÇ °¨¼Ò¿¡ ÀÇÇÑ °ÍÀÌ Àڹݺ´ÀÇ ÇüŸ¦ ÃëÇÑ´Ù. ©ç Ç÷°üº®ÀÇ ÀÌ»ó : ´Ü¼ø¼º Àڹݺ´À̳ª ±â°èÀû Àڱؿ¡ ÀÇÇÑ Àڹݺ´Àº Ưº°ÇÑ Ä¡·á¸¦ ÇÏÁö ¾Ê¾Æµµ ÀÚ¿¬È÷ ¼Ò½ÇµÇ´Â °ÍÀÌ ¸¹´Ù. Ä¡·áÀÇ Çʿ䰡 ÀÖ´Â ´ëÇ¥ÀûÀÎ °ÍÀº ¼é¶óÀÎ-Çì³ëÈå Àڹݺ´À¸·Î¼­, ¾Æ³ªÇʶô½Ã Àڹݺ´ ¶Ç´Â ¾Ë·¹¸£±â¼º Àڹݺ´À̶ó°íµµ ÇÏ´Â ÀÏÁ¾ÀÇ ¾Ë·¹¸£±â¼º ÁúȯÀÌ´Ù. µ¶¹° Áßµ¶, °¨¿°Áõ, ´ç´¢º´, ¿äµ¶Áõ µîÀÌ ¿øÀÎÀÌ µÇ´Â ¼ö°¡ ¸¹¾Æ ÀÌµé ¿øÀÎÁúȯÀÇ Ä¡·á°¡ ÁÖ°¡ µÇ´Â °æ¿ìµµ ÀÖ´Ù. ÇǺο¡ »ý±â´Â °ÍÀ» ¼é¶óÀÎ ÀÚ¹Ý, ¼ÒÈ­±âÀÇ Á¡¸·¿¡ »ý±â´Â °ÍÀ» Çì³ëÈå ÀÚ¹ÝÀ̶ó°í ÇÑ´Ù. ÀüÀÚ´Â ¾ÈÁ¤À» ÃëÇϸé ÀÚ¹ÝÀÇ ÃâÇöÀÌ Àû¾îÁö°í, ¹æÄ¡ÇÏ¿©µµ ÀÚ¿¬È÷ ¼Ò½ÇµÈ´Ù. ÈÄÀÚÀÇ °æ¿ì´Â ½ÉÇÑ º¹Åë ¿Ü¿¡ °üÀý¿°, ½Å°æÅë, ±ÙÀ°Åë, ½ÅÃâÇ÷ µîÀ» ÀÏÀ¸Å°°Å³ª Ç÷º¯ÀÌ ¹èÃâµÇ´Â ¼öµµ ÀÖÀ¸¹Ç·Î ±Þ¼º º¹¸·¿°, Ãæ¼ö¿°, ÀåÆó»ö µî°ú È¥µ¿µÇ±â ½±´Ù. º¸Åë µ¿½Ã¿¡ ³ªÅ¸³ª´Â ÀÏÀÌ ¸¹Áö¸¸, ´Üµ¶À¸·Î ³ªÅ¸³ª´Â ¼öµµ ÀÖ´Ù. Ä¡·á¾àÀ¸·Î¼­´Â ºÎ½Å ÇÇÁú ½ºÅ×·ÎÀ̵å
  • purpura allergica
    ¾Ë·¯Áö¼º ÀÚ¹Ý
  • purpura benign
    ¾ç¼º ÀÚ¹ÝÁõ
  • purpura erythematosa
    È«¹Ý¼º ÀÚ¹Ý
  • purpura hemorrhagica
    ÃâÇ÷¼º ÀÚ¹Ý
  • thrombasthenic purpura
    Ç÷¼ÒÆÇ Ãë¾à¼º Àڹݺ´
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
purpura, schoenlein-henoch A form of nonthrombocytopenic purpura due to a hypersensitivity vasculitis (vasculitis, hypersensitivity) associated with a variety of clinical symptoms including urticaria and erythema, arthropathy and arthritis, gastrointestinal symptoms, and renal involvement.
(12 Dec 1998)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
sch-23390 <chemical> 8-chloro-2,3,4,5-tetrahydro-3-methyl-5-phenyl-1h-3-benzazepin-7-ol. A dopamine d1 receptor antagonist that has no effect or only very limited effect on dopamine d2 receptors. The compound has tranquillising effects, inhibits conditioned avoidance response, impairs memory acquisition, produces dose-dependent catalepsy, blocks central serotonin receptors, and reduces the lethal effects of cocaine.
Pharmacological action: antipsychotic agents, dopamine antagonists.
Chemical name: 1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-3-methyl-5-phenyl-, (R)-
(12 Dec 1998)
acute vascular purpura <dermatology> This relatively rare disorder is characterised by skin purpura, joint pains, abdominal pain and renal disease (glomerulonephritis).
Although Henoch-Schonlein purpura or anaphylactoid purpura, is thought to be a immune complex mediated disease, its exact cause is unknown. Its typical benign coarse can, however, include renal failure.
(27 Sep 1997)
allergic purpura Nonthrombocytopenic purpura due to sensitization to foods, drugs, and insect bites.
Synonym: anaphylactoid purpura.
(05 Mar 2000)
anaphylactoid purpura <dermatology> This relatively rare disorder is characterised by skin purpura, joint pains, abdominal pain and renal disease (glomerulonephritis).
Although Henoch-Schonlein purpura or anaphylactoid purpura, is thought to be a immune complex mediated disease, its exact cause is unknown. Its typical benign coarse can, however, include renal failure.
(27 Sep 1997)
autoimmune thrombocytopenia purpura <haematology> A rare autoimmune disorder characterised by an acute shortage of platelets with resultant bruising and spontaneous bleeding.
The platelet count becomes exceedingly low and spontaneous bleeding from the gums, gastrointestinal tract and nose can be seen. Physical examination may demonstrate enlargement of the spleen. A typical rash occurs to do microscopic haemorrhage of small blood vessels in the skin.
Platelet counts under 10,000 can lead to spontaneous haemorrhage into the brain causing death. Treatment with corticosteroids is generally effective. Surgical removal of the spleen (splenectomy) is reserved for some patients.
Anti-platelet antibodies are detectable in some cases. It may present in either an acute or a chronic form.
Acronym: ITP
(20 Sep 2002)
Waldenstrom's purpura <haematology> A condition characterised by proliferation of cells resembling lymphocytes or plasma cells in the bone marrow, anaemia, increased sedimentation rate and hyperglobulinaemia. Physical findings include mucosal bleeding, skin purpura and enlargement of the lymph nodes, liver and spleen.
(27 Sep 1997)
Henoch-Schonlein purpura <dermatology> This relatively rare disorder is characterised by skin purpura, joint pains, abdominal pain and renal disease (glomerulonephritis).
Although Henoch-Schonlein purpura or anaphylactoid purpura, is thought to be a immune complex mediated disease, its exact cause is unknown. Its typical benign coarse can, however, include renal failure.
(27 Sep 1997)
Henoch's purpura <dermatology> This relatively rare disorder is characterised by skin purpura, joint pains, abdominal pain and renal disease (glomerulonephritis).
Although Henoch-Schonlein purpura or anaphylactoid purpura, is thought to be a immune complex mediated disease, its exact cause is unknown. Its typical benign coarse can, however, include renal failure.
(27 Sep 1997)
Schonlein's purpura <dermatology> This relatively rare disorder is characterised by skin purpura, joint pains, abdominal pain and renal disease (glomerulonephritis).
Although Henoch-Schonlein purpura or anaphylactoid purpura, is thought to be a immune complex mediated disease, its exact cause is unknown. Its typical benign coarse can, however, include renal failure.
(27 Sep 1997)
psychogenic purpura <syndrome> A condition, usually occurring in women, in which the individual bruises easily (purpura simplex) and the ecchymoses tend to enlarge and involve adjacent tissues, resulting in pain in the affected parts; so-called because similar lesions are produced by inoculation of the individual's blood or various components of red blood cells and it is thought to be a form of localised autosensitization, although no specific antibodies have been demonstrable; in some individuals, there seems to be a psychogenic mechanism.
Synonym: Gardner-Diamond syndrome, psychogenic purpura.
(05 Mar 2000)
purpura <clinical sign, dermatology> A small haemorrhage (up to about 1 cm in diameter) in the skin, mucous membrane or serosal surface, which may be caused by various factors, including blood disorders, vascular abnormalities and trauma.
Purpuric lesions may be associated with inflammation, in which case they present as papular purpura or the haemorrhage may not be accompanied by inflammation, in which case they are macular.
The term also comprises a group of haemorrhagic diseases characterised by the presence of purpuric lesions, ecchymoses and a tendency to bruise easily, which may be caused by decreased platelet counts, the presence of abnormal platelets, vascular defects or reactions to certain drugs.
(15 Dec 1997)
purpura, anaphylactoid See Purpura, Henoch-Schonlein.
(12 Dec 1998)
purpura angioneurotica An eruption marked by angioneurotic oedema, petechiae, and hyperesthesia of the skin and gastric mucous membrane.
(05 Mar 2000)
purpura annularis telangiectodes Asymptomatic annular lesions, principally of the lower extremities of adolescent males, in which the peripheral portion is composed of purpura or petechiae with brawny staining of haemosiderin deposits and minute telangiectasia.
Synonym: Majocchi's disease.
(05 Mar 2000)
purpura fulminans A severe and rapidly fatal form of purpura haemorrhagica, occurring especially in children, with hypotension, fever, and disseminated intravascular coagulation, usually following an infectious illness.
(05 Mar 2000)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 1 ÆäÀÌÁö: 1
  • Purpura, Schoenlein-Henoch - »õâ A form of nonthrombocytopenic purpura due to a hypersensitivity vasculitis associated with a variety of clinical symptoms including urticaria and erythema, arthropathy and arthritis, gastrointestinal symptoms, and renal involvement.
    Synonyms : Purpura, Nonthrombopenic, Fulminans, Purpura, Hemorrhagic Vasculitis, Hemorrhagica, Purpura, Henoch Schoenlein Purpura, Nonthrombocytopenic Purpura, Nonthrombopenic Purpura, Nonthrombopenic Purpuras, Purpura, Allergic, Purpura, Anaphylactoid, Purpura, Henoch
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á